These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 16791717)

  • 1. A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain.
    Fornos JA; Andrés NF; Andrés JC; Guerra MM; Egea B
    Pharm World Sci; 2006 Apr; 28(2):65-72. PubMed ID: 16791717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil.
    Correr CJ; Melchiors AC; Fernandez-Llimos F; Pontarolo R
    Int J Clin Pharm; 2011 Apr; 33(2):273-80. PubMed ID: 21394570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a community pharmacy-based medication therapy management program on clinical and humanistic outcomes in patients with uncontrolled diabetes: a randomised controlled trial.
    Albabtain B; Bawazeer G; Paudyal V; Cheema E; Alqahtani A; Bahatheq A; Price MJ; Hadi MA
    Sci Rep; 2024 Aug; 14(1):17818. PubMed ID: 39090152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study.
    Ali M; Schifano F; Robinson P; Phillips G; Doherty L; Melnick P; Laming L; Sinclair A; Dhillon S
    Diabet Med; 2012 Sep; 29(9):e326-33. PubMed ID: 22672148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.
    Pousinho S; Morgado M; Falcão A; Alves G
    J Manag Care Spec Pharm; 2016 May; 22(5):493-515. PubMed ID: 27123912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial.
    Mehuys E; Van Bortel L; De Bolle L; Van Tongelen I; Annemans L; Remon JP; Giri M
    J Clin Pharm Ther; 2011 Oct; 36(5):602-13. PubMed ID: 21143256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of diabetes indices of care by a short pharmaceutical care program.
    Turnacilar M; Sancar M; Apikoglu-Rabus S; Hursitoglu M; Izzettin FV
    Pharm World Sci; 2009 Dec; 31(6):689-95. PubMed ID: 19777365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of diabetes education and short message service reminders on metabolic control and disease management in patients with type 2 diabetes mellitus.
    Güner TA; Coşansu G
    Prim Care Diabetes; 2020 Oct; 14(5):482-487. PubMed ID: 32471770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients.
    Davidson J; Koro C; Arondekar B; Lee BH; Fedder D
    Clin Ther; 2008 Feb; 30(2):287-93. PubMed ID: 18343267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist-Managed Diabetes Center Interventions Ensure Quality and Safety in Elderly Patients.
    Twigg G; Motsko J; Thomas J; David T
    Consult Pharm; 2017 May; 32(5):299-310. PubMed ID: 28483010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus.
    Al Mazroui NR; Kamal MM; Ghabash NM; Yacout TA; Kole PL; McElnay JC
    Br J Clin Pharmacol; 2009 May; 67(5):547-57. PubMed ID: 19552750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.
    Herz M; Johns D; Reviriego J; Grossman LD; Godin C; Duran S; Hawkins F; Lochnan H; Escobar-Jiménez F; Hardin PA; Konkoy CS; Tan MH
    Clin Ther; 2003 Apr; 25(4):1074-95. PubMed ID: 12809958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
    Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
    PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial.
    Chen JH; Ou HT; Lin TC; Lai EC; Kao YH
    Int J Clin Pharm; 2016 Feb; 38(1):88-95. PubMed ID: 26499503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.
    Moretto TJ; Milton DR; Ridge TD; Macconell LA; Okerson T; Wolka AM; Brodows RG
    Clin Ther; 2008 Aug; 30(8):1448-60. PubMed ID: 18803987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of PRECEDE model for health education on changes and level of control of HbA1c, blood pressure, lipids, and body mass index in patients with type 2 diabetes mellitus.
    Salinero-Fort MA; Carrillo-de Santa Pau E; Arrieta-Blanco FJ; Abanades-Herranz JC; Martín-Madrazo C; Rodés-Soldevila B; de Burgos-Lunar C
    BMC Public Health; 2011 Apr; 11():267. PubMed ID: 21524316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a community pharmacist-delivered diabetes support program for patients receiving specialty medical care: a randomized controlled trial.
    Jahangard-Rafsanjani Z; Sarayani A; Nosrati M; Saadat N; Rashidian A; Hadjibabaie M; Ashouri A; Radfar M; Javadi M; Gholami K
    Diabetes Educ; 2015 Feb; 41(1):127-35. PubMed ID: 25420946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of therapy with metformin plus pioglitazone in the treatment of patients with type 2 diabetes: a double-blind, placebo-controlled, clinical trial.
    Kaku K
    Curr Med Res Opin; 2009 May; 25(5):1111-9. PubMed ID: 19309251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study investigating the impact of pharmacist involvement on the outcomes of diabetes medication therapy adherence program Malaysia.
    Lim PC; Lim K; Embee ZC; Hassali MA; Thiagarajan A; Khan TM
    Pak J Pharm Sci; 2016 Mar; 29(2):595-601. PubMed ID: 27087103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.